Technology

Xeris Pharmaceuticals

$5.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.27 (-4.80%) Today
-$0.01 (-0.19%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell XERS and other stocks, options, and ETFs commission-free!

About XERS

Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. The listed name for XERS is Xeris Pharmaceuticals, Inc. Common Stock.

CEO
Paul R. Edick
Employees
202
Headquarters
Chicago, Illinois
Founded
2005
Market Cap
250.37M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.14M
High Today
$5.67
Low Today
$5.25
Open Price
$5.67
Volume
1.38M
52 Week High
$7.16
52 Week Low
$1.42

Collections

XERS Earnings

-$1.28
-$0.85
-$0.43
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

TTDKY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure